RA Capital Extends ARTV Buying Streak to $3M in Four Days
RA Capital Management, L.P. added another purchase to its recent run of open-market buys in Artiva Biotherapeutics, Inc. (ARTV), according to a Form 4 filed with the SEC. On July 24, 2026, the investment firm bought 41,319 shares at $9.99 apiece, a purchase worth $412,776.81. Following the transaction, RA Capital’s indirectly held stake stands at … Read more